Eurazeo (RF) - Total Liabilities
Based on the latest financial reports, Eurazeo (RF) has total liabilities worth €1.70 Billion EUR (≈ $1.98 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Eurazeo growing its equity to track the company's year-over-year net asset growth rate.
Eurazeo - Total Liabilities Trend (2003–2025)
This chart illustrates how Eurazeo's total liabilities have evolved over time, based on quarterly financial data. See Eurazeo (RF) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Eurazeo Competitors by Total Liabilities
The table below lists competitors of Eurazeo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Orient Holdings Co Ltd
SHG:600120
|
China | CN¥44.10 Billion |
|
BSP Financial Group Ltd
AU:BFL
|
Australia | AU$37.82 Billion |
|
AUB Group Ltd
AU:AUB
|
Australia | AU$2.77 Billion |
|
Uxi Unicomp Technology Co. Ltd. A
SHG:688531
|
China | CN¥516.58 Million |
|
Disc Medicine Inc.
NASDAQ:IRON
|
USA | $61.78 Million |
|
Bausch Health Companies Inc
TO:BHC
|
Canada | CA$25.58 Billion |
|
Co-Tech Development
TWO:8358
|
Taiwan | NT$1.91 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Eurazeo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Eurazeo market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurazeo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurazeo (2003–2025)
The table below shows the annual total liabilities of Eurazeo from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.70 Billion ≈ $1.98 Billion |
-9.32% |
| 2024-12-31 | €1.87 Billion ≈ $2.19 Billion |
+32.47% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
-85.25% |
| 2022-12-31 | €9.57 Billion ≈ $11.19 Billion |
+20.69% |
| 2021-12-31 | €7.93 Billion ≈ $9.27 Billion |
+2.65% |
| 2020-12-31 | €7.73 Billion ≈ $9.04 Billion |
+6.07% |
| 2019-12-31 | €7.29 Billion ≈ $8.52 Billion |
+24.68% |
| 2018-12-31 | €5.84 Billion ≈ $6.83 Billion |
+4.92% |
| 2017-12-31 | €5.57 Billion ≈ $6.51 Billion |
+8.27% |
| 2016-12-31 | €5.14 Billion ≈ $6.01 Billion |
+95.79% |
| 2015-12-31 | €2.63 Billion ≈ $3.07 Billion |
-70.10% |
| 2014-12-31 | €8.79 Billion ≈ $10.27 Billion |
-0.46% |
| 2013-12-31 | €8.83 Billion ≈ $10.32 Billion |
-13.50% |
| 2012-12-31 | €10.21 Billion ≈ $11.93 Billion |
-4.44% |
| 2011-12-31 | €10.68 Billion ≈ $12.49 Billion |
+4.41% |
| 2010-12-31 | €10.23 Billion ≈ $11.96 Billion |
-5.20% |
| 2009-12-31 | €10.79 Billion ≈ $12.62 Billion |
-3.47% |
| 2008-12-31 | €11.18 Billion ≈ $13.07 Billion |
+3.07% |
| 2007-12-31 | €10.85 Billion ≈ $12.68 Billion |
+2204.45% |
| 2003-12-31 | €470.68 Million ≈ $550.27 Million |
-- |
About Eurazeo
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, … Read more